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Abstract (limit: 250 words)
Background: Invasive gastric electrical mapping has revealed spatial 
abnormalities of the slow wave are present among subjects with gastroparesis and 
functional gastrointestinal disorders.  The cutaneous high resolution 
electrogastrogram (HR-EGG) can non-invasively detect spatial features of the 
gastric slow wave.  In this study, we performed HR-EGG on subjects with 
gastroparesis and functional dyspepsia with normal gastric emptying, evaluating for
associations between gastric myoelectric abnormalities, symptoms on a validated 
questionnaire, and gastric emptying.
Methods: HR-EGG was performed on 32 subjects (7 controls, 7 functional 
dyspepsia with normal gastric emptying, 18 gastroparesis).  Subjects completed the
PAGI-SYM questionnaire on foregut symptoms, which includes the Gastroparesis 
Cardinal Symptom Index (GCSI).   Volume reconstruction of the torso and stomach 
from CT images was performed to guide accurate placement of the HR-EGG array.
Results: Spatial abnormalities were detected noninvasively in 44% of subjects with
foregut symptoms.  Moreover, subjects with a higher percentage of slow waves with
abnormal propagation direction had a higher GCSI total score (r = 0.56, p < .001) 
and more severe abdominal pain (r = 0.46, p = .009).  We found no significant 
correlation between symptoms and traditional EGG parameters.
Conclusions:  The genesis of symptoms in functional dyspepsia and gastroparesis 
is likely multifactorial, including possible pathophysiologic contribution from gastric 
myoelectric dysfunction.  We report here that abnormal spatial parameters on 
cutaneous HR-EGG correlated robustly with severity of upper gastrointestinal 
symptoms, regardless of gastric emptying.  This noninvasive, repeatable approach 
will allow for assessment of slow wave dynamics across time, including symptom-
association analyses and response to targeted therapies.
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Introduction
Functional dyspepsia and gastroparesis are the two most common gastric 
neuromuscular disorders with a prevalence of 10% and 1.5-3%, respectively (1,2).  
Although delayed gastric emptying is the sine qua non of gastroparesis, symptoms 
show inconsistent correlation with emptying on scintigraphy or gastric transit time 
via the wireless motility capsule (3,4).  Moreover, multiple medications improve 
symptoms but not gastric emptying and vice versa (5–7).  It has been proposed that
functional dyspepsia and gastroparesis should be subtyped for more specificity and 
targeted interventions (8,9).  Specifically, impaired fundic accommodation, gastric 
myoelectric dysfunction, antral hypomotility, pylorospasm, autonomic dysfunction, 
visceral hypersensitivity, duodenal dysmotility, psychosocial stress, and central 
nervous system abnormalities, which can all lead to symptoms, may need to be 
differentiated to provide more tailored treatment strategies (9–11).
The electrogastrogram (EGG) is a technique for assessing gastric myoelectric 
activity using cutaneous electrodes (12).  Although it is noninvasive and easy to 
administer, EGG has limitations that have prevented widespread uptake.  While 
some studies have observed EGG abnormalities in patients with upper 
gastrointestinal symptoms (13–15), other studies have found no differences 
between dyspeptic patients and healthy volunteers (16,17).  Moreover, its clinical 
usefulness has been questioned, due to insufficient correlation with diagnoses made
via antroduodenal manometry (18) and gastric emptying tests (12).  There remains 
an unmet need to objectively assess gastric neuromuscular function in a 
noninvasive manner that correlates with symptoms and can be easily used to guide 
targeted therapies.
High-resolution invasive electrical mapping allows for spatially detailed analysis of 
propagating slow wave patterns directly from the serosa of the stomach (19).  Using
this approach, abnormalities in slow wave initiation and propagation have been 
identified among subjects with gastroparesis and chronic unexplained nausea and 
vomiting (20,21).  These findings indicate that the slow wave spatial electrical 
patterns may be associated with disease and symptom severity.  As such, there is a
unique opportunity to develop non-invasive means to detect this spatial electrical 
information and determine if these patterns show similar clinical associations.
The recently developed high-resolution electrogastrogram (HR-EGG) utilizes a 
cutaneous multielectrode array to estimate spatial parameters of slow wave 
propagation. This has been performed successfully in estimating the direction and 
speed of the gastric slow wave in healthy subjects (22).  The objective of this study 
was to determine whether the HR-EGG, combined with methodological refinements 
consisting of enhanced artifact rejection technique and array placement (23), 
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provides quantitative descriptions of the gastric slow wave that differentiate 
subjects with and without foregut symptoms.  We also sought to evaluate 
associations between novel HR-EGG parameters, traditional EGG features, foregut 
symptoms on validated questionnaire, and gastric emptying.
Methods
Participants
We enrolled 32 subjects in this study; age 21 to 85 years old, BMI 16 to 36 kg/m2, 
17F/15M.  We divided subjects into three groups: healthy controls (n=7), functional 
dyspepsia as defined by Rome III criteria (24) with normal gastric emptying (n=7), 
and gastroparesis (n=18).  A summary of detailed subject characteristics can be 
found in Table 1.  Patients were recruited from a tertiary referral gastrointestinal 
motility program and provided their informed consent.  We documented 
demographic data, disease etiology, medical histories, and body mass index for 
each subject.  The study included subjects with any ethnic background older than 
18 years of age who had a recent fasting abdominal computed tomography (CT) 
scan (i.e., within 3 years).  Subjects with malignancy, primary eating disorder, 
pregnancy, or a history of skin allergies to adhesives or ECG electrodes were 
excluded.  Subjects were also excluded if they had a disorder other than functional 
dyspepsia or gastroparesis that affects gastric motility, including rumination 
syndrome, cyclic vomiting syndrome, untreated H. pylori Infection, gastric outlet 
obstruction, small bowel motility problem, or uncontrolled thyroid disease.
Gastric Emptying Scintigraphy
Gastric emptying scintigraphy was completed at a single medical center, the UC 
San Diego Department of Nuclear Medicine.  Patients were instructed to stop taking 
any medications that could affect motility (e.g., prokinetics, opioids, anti-
cholinergics) for at least two days prior to the gastric emptying study.  The blood 
glucose level in diabetic subjects were tested prior to the study to ensure it was 
below 250 mg/dL, as hyperglycemia has been shown to change gastric emptying 
(25).  The study was performed according to the clinical guidelines using a 
technetium-99m labeled egg meal (26).  Anterior and posterior images were 
obtained at 0, 1, 2, 3, and 4 hours after meal ingestion.  Gastric retention of the 
meal was determined by calculating the geometric mean of the radioactivity, 
corrected for decay, within the stomach region of interest (27).  We defined 
abnormal emptying as having gastric retention greater than 10% at 4 hours.
Abdominal CT Image Processing
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We used recent abdominal CT scans to determine the location and geometry of 
each subject’s stomach.  A single operator manually drew a region of interest (ROI) 
outlining the stomach on each axial slice in OsiriX (28).  We then performed a 3D 
volume reconstruction of the torso and stomach for each subject (see Supplemental
Materials).  We developed a custom routine to automatically calculate the medial 
line of the stomach using the manually drawn ROIs.  The procedure was as follows: 
(i) the isolated stomach was exported as an STL file; (ii) the STL volume was 
converted to a binary 3D matrix (i.e., voxelized); (iii) using a thinning procedure 
(29), the stomach was skeletonized to reveal the medial line.  We determined the 
3D location of the pylorus by calculating the endpoint of the medial line and 
confirmed by identifying the pylorus in the CT images.  We noted the position of the
pylorus relative to the midpoint between the xiphoid and umbilicus, which is 
typically used for traditional EGG electrode placement.  We used standard linear 
algebra methods to project the three-dimensional medial line onto the coronal plane
to compute the stomach angle relative to the electrode array.
High-Resolution EGG
We recorded the high-resolution electrogastrogram (HR-EGG) as previously 
described, using a cutaneous array of 25 pregelled Ag-AgCl electrodes 
(measurement area 95 mm2) arranged in a five-by-five grid with 2 cm center-to-
center spacing (22).  We performed all recordings in the morning after an overnight 
fast.  Following the same protocol as the gastric emptying study, subjects were off 
medications that affect motility for at least two days and we ensured the blood 
glucose levels in diabetics was below 250 mg/dL.  Prior to placing the electrode 
array, we removed excess hair and prepared the skin with NuPrep® to reduce skin 
impedance.  We placed the array over the antrum by localizing the stomach relative
to anatomical landmarks from the subject’s anatomical CT scan.  We placed 
reference and ground electrodes on the subject’s right side outside of the array 
(Figure 1).  We used the Brainamp 32ch EEG amplifier (Brain Products, Gilching, 
Germany) to collect unfiltered data at sampling rate of 250Hz.  During the 
recording, subjects sat in a reclined position and were instructed to limit movement 
and talking.  We captured 30 minutes preprandial and 60 minutes after a test meal 
that included a 250-kcal nutrient bar (CLIF Bar: 5 g fat, 45 g carbohydrate, 10 g 
protein, 7 g fiber) and 8 ounces of room temperature water.  We had no adverse 
events during the recordings and the test was well tolerated by the subjects.
Prior to data analysis, we reduced the sampling rate of the recorded signals from 
each electrode to 5 Hz after low pass filtering the signal to lower computational 
time.  We then filtered between 0.015 and 0.20 Hz (i.e., 1-20 cpm) to isolate the 
EGG frequency bands of interest.  We removed any movement artifacts as 
described previously (23).  In brief, we identified any artifact using linear minimum 
mean squared error (LMMSE) estimator and subsequently subtracted it from each 
individual waveform.  This approach was fully automated and preserved the phase 
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across electrodes because windows of time were not deleted.  We have previously 
shown that this approach yields an improvement in the correlation of EGG with an 
invasive clinically indicated measure (i.e., manometry) (23).
We applied the HR-EGG analysis as described previously (22).  In brief, the phase 
changes across the electrode array were calculated at every time point, from which 
the presence, direction, and speed of planar waves were automatically estimated.  
Prior to analysis, we used the average reference spatial filter instead of the surface 
Laplacian (30).  We found it was more robust at high BMI since the surface 
Laplacian suppresses deep sources (31).  Phase gradient directionality (PGD) is a 
measure between 0 and 1 indicating the degree of alignment of the phase gradients
across the array.  We defined a sustained wave as having a PGD greater than 0.5 
for at least 10 seconds (22).  We defined the anterograde (i.e., normal) direction of 
wave propagation along the mean angle of the stomach ± 60 degrees to account 
for J-shaped stomachs, inaccuracies due to the delay between CT imaging and 
recording, and changes in stomach shape after a meal.  We defined the percent 
abnormal direction as the percentage of slow waves not propagating in the 
anterograde direction.  We considered each spatial feature (e.g., percent abnormal 
direction and speed) to be abnormal if it was below 1.96 standard deviations of the 
mean pertaining to the control group data.
Traditional EGG
We computed short-time Fourier transform spectrograms for each electrode pair by 
dividing the time domain into consecutive four-minute windows with 75% overlap.  
We calculated traditional EGG parameters from the electrode pair with the highest 
signal-to-noise ratio (SNR), which we defined as the average 2-4 cpm power (in dB) 
subtracted from the average power in all other frequencies between 1 and 9 cpm 
(23).  Consistent with traditional EGG practice (32), we defined: (i) postprandial 
power change as the difference of the mean power in the 2-4 cpm frequency band 
before and after the meal (in dB); (ii) dominant frequency in each time window as 
the frequency with the highest spectral power; (iii) percentage of normal, 
bradygastria, and tachygastria activity as the fraction of the recording with the 
highest power in the 2-4 cpm, 1-2 cpm, and 4-9 cpm frequency band, respectively.
Symptom Assessment
We assessed symptom severity in subjects with the Patient Assessment of Upper 
Gastrointestinal Symptoms (PAGI-SYM) questionnaire prior to recordings (33).  The 
PAGI-SYM captures 20 symptoms on a 0-5 scale experienced by the subjects within 
the previous two weeks.  It also contains the Gastroparesis Cardinal Symptom Index
(GCSI), which combines the individual symptom scores into three subscales: 
nausea/vomiting, postprandial fullness/early satiety, and bloating/distension (34).
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Statistical Analysis
Data are presented as numbers with percentages for categorical variables and 
mean ± standard deviation for continuous variables.  Results were divided into 
three groups: control, functional dyspepsia with normal gastric emptying, and 
gastroparesis.  For the categorical variables, we employed Fisher’s exact test to 
determine independence of observed frequencies in the contingency tables.  We 
used one-way analysis of variance (ANOVA) for continuous variables to test the null 
hypothesis that the three groups have the same population mean.  Prior to ANOVA, 
we confirmed that samples within groups belonged to a normal distribution using 
D’Agostino’s K2 test, and used Bartlett’s test to verify that the distributions from 
each group had equal variances.  For variables with statistically significant 
differences in means between groups identified by ANOVA, we did pairwise 
comparisons between individual groups using a two-sided unpaired t-test and 
reported the p values with no correction.  We determined the associations between 
all the study variables (e.g., subject characteristics, EGG, symptoms) by calculating 
the Pearson’s correlation coefficient, a measure of the linear correlation between 
two variables.  We reported statistically significant correlations after Benjamini-
Hochberg correction (family-wise error rate alpha = 0.05) for all variables to avoid 
Type-I errors and reduce the false discovery rate (35).
Results
Subject Characteristics
Demographic and relevant medical information are included in Table 1 for the three 
groups in this study; controls, functional dyspepsia with normal gastric emptying, 
and gastroparesis.  The groups were age, sex, and BMI matched, and the ethnicity 
of the subjects in this study were representative of the San Diego area.  There were 
no significant differences in the subject characteristics between the three groups, 
with the exception of opioid use and diabetes, that were more common in the 
subjects with gastroparesis.  There were a wide range of etiologies for gastroparesis
and all except one of the subjects with gastroparesis also fit the Rome III criteria for 
functional dyspepsia.  One of the subjects in the study had a gastric surgery, 
fundoplication, which can affect gastric emptying and function (36).
Anatomical Variability
Since previous studies have shown that stomach localization can greatly improve 
EGG signal quality (23,37), we evaluated the stomach location relative to traditional
EGG electrode placement to determine variability across subjects.  Specifically, for 
each subject, we plotted the location of the pylorus on a coronal and sagittal views 
of a representative torso relative to the midpoint of the xiphoid and umbilicus, 
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which is where traditional EGG electrodes are placed (Figure 2).  We found the most
variability along the inferior-superior axis.  The mean location of the pylorus relative
to the midpoint of the xiphoid and umbilicus was -3.1 ± 1.9 cm (range: -6.7 to 1.7 
cm) in the right-left direction, 1.3 ± 3.9 cm (range: -5.8 - 8.4 cm) in the inferior-
superior direction, and 7.4 ± 3.0 cm (range: 1.7 - 14.3 cm) anterior-posterior 
direction.  The mean fasting stomach volume determined from the abdominal CT 
images was 309 ± 176 cm3 (range 132 - 740 cm3) and the mean stomach angle was
202 ± 13 degrees (range: 180 - 233 degrees) across all subjects.  Besides the 
significant variability in stomach location between subjects, there were also a wide 
range of stomach shapes (e.g., steer-horn, cascade, J-shape, hourglass) (see Figure 
3 for volumetric stomach reconstructions; Supplemental Materials includes all 
subjects).
Traditional EGG
We observed a clear EGG signal in most subjects in this study; percent 2-4 cpm 
activity was 95 ± 6 % (range 83 - 100 %) for all subjects.  Only four subjects (2/7 
functional dyspepsia and 2/18 gastroparesis) had a low amplitude EGG signal that 
was near the background noise level (see Supplemental Materials for spectrograms 
for each subject).  The slow wave frequency was 0.053 ± 0.005 Hz (range: 0.044 - 
0.066 Hz) and the postprandial power change was 2.7 ± 4.0 dB (range: -3.5 - 14.4 
dB) for all subjects.  Six subjects (1/7 functional dyspepsia and 5/18 gastroparesis) 
did not have an increase in EGG power after the meal.  There were no significant 
differences between groups for any of the traditional EGG parameters (Table 2).
High-Resolution EGG
We conducted HR-EGG recordings in the morning after an overnight fast; the mean 
start time was 10:34 AM ± 1:09.  From the imaging, we computed the direction of 
the stomach projected onto the plane of the electrode array (see Methods).  This 
direction was used to define a subject-specific window (mean angle ± 60 degrees); 
slow wave propagation direction within this window was considered normal (Figure 
3; see green region on polar histogram).  The mean time between abdominal CT 
imaging and the HR-EGG recordings was 1.6 ± 1.3 years.
The control group had the majority of slow waves propagating within the CT-defined
normal axis of the stomach.  We detected abnormalities in the propagation direction
(i.e., greater than 45% abnormal direction) or speed (i.e., mean less than 5 mm/s) in
14 subjects (6/7 functional dyspepsia and 8/18 gastroparesis).  Of the 14 subjects 
with spatial abnormalities, five had both speed and direction abnormalities, five 
only had slow propagation speed, and four had abnormal propagation direction with
normal speeds.  Of the nine subjects with direction abnormalities, six had a 
combination of anterograde and retrograde propagation, while the remaining three 
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had chaotic propagation patterns (see Figure 3 for representative patterns; 
Supplemental Materials includes results for each subject).  Most of these spatial 
abnormalities occurred at the normal EGG frequency.  The one subject in this study 
with previous fundoplication surgery had slow wave propagation abnormalities.  
There were no significant associations for drug use, gastroparesis etiology, diabetes
type or demographics differentiating those with slow wave spatial abnormalities.  
The percentage of sustained slow waves along with its speed were significantly 
higher in the controls compared to functional dyspepsia and gastroparesis (Table 2).
The HR-EGG parameters were not statistically different between the functional 
dyspepsia and gastroparesis groups.
Relationships with Symptoms
As expected, subjects with functional dyspepsia and/or gastroparesis had more 
severe symptoms compared to controls (Table 2).  The mean GCSI score, 
particularly the nausea-vomiting subtype, was higher in gastroparesis compared to 
functional dyspepsia with normal gastric emptying.
Statistically significant correlations between study variables are displayed in a 
circular plot in Figure 4 (see Supplementary Figure 1 for all correlation coefficients). 
Anthropomorphic characteristics (e.g., BMI, age, or stomach volume) were not 
significantly correlated with any patient-reported or objective measures in the 
study.  Gastric retention at 4 hours was measured on symptomatic subjects (n = 
25) and correlated with only two of the symptoms: unable to finish normal-sized 
meal (p = .009) and upper abdominal discomfort (p = .01).  Despite CT-guided 
localization of the array and motion artifact rejection, traditional EGG parameters 
failed to associate with any clinical symptom.
All three spatial features of the HR-EGG predicted the quantity and intensity of 
foregut symptoms.  Specifically, abnormalities in slow wave propagation direction 
correlated with the overall GCSI score (p < .001), bloating/distension (p = .003), 
fullness/early satiety (p < .001), abdominal discomfort (lower: p = 0.01; upper: p 
< .018), and lower abdominal pain (p = .009).  Globally, subjects without 
anterograde propagation of their slow wave, regardless of gastric emptying status, 
reported the most severe symptoms (see Figure 5).
Discussion
In this manuscript, we presented data from 32 healthy controls and well-
characterized patients with active foregut symptoms.  We applied recently 
developed approaches to noninvasively characterize gastric myoelectrical activity in
high spatiotemporal detail.  We accounted for differences in gastric anatomy by 
generating subject-specific volumetric torso reconstructions from CT imaging.  
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Using data from an appropriately placed cutaneous electrode array, we 
automatically rejected movement artifacts (23) and estimated features of slow 
wave propagation (22) in addition to traditional EGG parameters.  These 
methodological improvements resulted in a robust acquisition of the gastric slow 
wave in subjects with BMI up to 36.  Moreover, we observed abnormal slow wave 
propagation in subjects with functional dyspepsia and/or gastroparesis compared to 
healthy controls.  The key finding of this study was a statistically significant 
correlation between the percentage of slow waves with abnormal propagation 
direction and overall foregut symptom severity, regardless of gastric emptying.
Even though traditional EGG studies considered greater than 70% of the recording 
with 3 cpm activity to be normal (12), fewer rhythm disruptions have been observed
on serosal measurements (38,39).  By guiding electrode array placement with CT 
imaging and automatically suppressing artifacts, we observed 3 cpm activity in 
most subjects, including those with impaired gastric emptying.  We have previously 
shown that these methodological refinements resulted in an improved correlation of
EGG amplitude with motility index on antroduodenal manometry (23).  These 
findings are also consistent with other studies that demonstrated electrode 
placement guided by stomach localization significantly improved EGG signal quality 
(37,40).  Although we did not find a difference in traditional EGG parameters 
between groups, future studies with longer recordings (e.g., ambulatory monitoring)
may be able to identify spectral features that correspond with abnormalities.
Multichannel EGG measurements (i.e., typically up to 4 channels) have been carried
out previously (41).  Although aboral slow wave propagation was observed in 
patients with foregut symptoms (42), the only reproducible parameter was found to 
be the average percentage of slow wave coupling, which compares spectral 
features between channels (43).  We believe this is due to sensitivity of 
multichannel EGG to electrode placement; if the reference electrode is placed near 
the antrum, a phase delay will not be observed between channels (41).  Our method
captures wave propagation information (i.e., not frequency-based coupling) and is 
not dependent on placement of the reference electrode.  This is important, since 
there is a significant amount of anatomical variability between subjects in both the 
location and shape of the human stomach (see Figure 2 and Supplemental 
Materials).
High-resolution electrical mapping of the gastric serosa in humans has shown that 
spatial slow wave abnormalities are present in patients with gastroparesis and 
chronic unexplained nausea and vomiting (20,21).  These included conduction 
blocks, aberrant initiation, and abnormal conduction velocity, which often occurred 
at the normal 3 cpm frequency.  Our results are consistent with those studies.  
Similar to their findings in fasting subjects under anesthesia, we observed both 
fasting and postprandial spatial disruption in slow wave direction and speed in 
awake subjects.  These abnormalities would go undetected by single channel EGG 
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measurements, since most occurred at the normal 3 cpm frequency.  Both slow 
wave speed and percentage of sustained waves were reduced in functional 
dyspepsia and gastroparesis compared to controls, and abnormalities in the 
direction of slow wave propagation correlated with a variety of important 
symptoms.
Although multiple simultaneous wavefronts exist on the stomach surface (19), we 
hypothesize that the HR-EGG findings in this study reflect slow wave propagation 
through the antrum, due to the higher amplitude of antral slow waves and their 
proximity to the electrode array (44).  It should be noted that the estimated slow 
wave speed for controls was higher than reported in our previous study (22).  This is
because we used a different spatial filter (i.e., average reference instead of surface 
Laplacian), which we found to be more robust at high BMI.  Additional theoretical 
and experimental validation is necessary to determine the relationship between the 
estimated cutaneous HR-EGG speed and the actual serosal slow wave speed.  It also
remains to be seen how the retrograde and chaotic propagation abnormalities 
observed with HR-EGG are related to those measured on the serosa (e.g., 
conduction block, abnormal initiation).
Consistent with other studies, we found a weak correlation of symptoms and EGG 
parameters with gastric emptying.  We observed slow wave abnormalities in 
symptomatic subjects with both normal and abnormal gastric emptying.  Unlike the 
gastric emptying results, HR-EGG abnormalities correlated with a variety of 
symptoms.  For example, the degree of abnormal slow wave direction was 
associated with abdominal pain and discomfort, which is not a cardinal symptom in 
gastroparesis but a predominant one in functional dyspepsia (24).  Collectively, 
these findings suggest the HR-EGG may be particularly attractive within the context
of functional dyspepsia, irrespective of gastric motor function.  Abnormal spatial 
slow wave propagation did not explain all symptoms, though; there was a subset of 
symptomatic subjects (i.e., 11/25 subjects) with normal slow wave propagation.  
Therefore, we hypothesize that HR-EGG may identify the subset of patients with 
functional dyspepsia and gastroparesis for whom gastric myoelectric dysfunction is 
an important pathophysiologic contributor to their condition. 
Loss of interstitial cells of Cajal (ICC) has been identified as an potential biomarker 
in the pathogenesis of gastroparesis (45).  It has been associated with gastric 
emptying (46) as well as gastric dysrhythmias measured from both the serosal (20) 
and cutaneous (47) surfaces.  Loss of ICC has also been observed in chronic 
unexplained nausea and vomiting with normal gastric emptying, albeit to a lesser 
degree than in gastroparesis (21).  Histological studies combined with HR-EGG can 
aid in determining the causality of symptoms and inform future therapies.
One limitation of our study was that the CT imaging was not performed at the time 
of electrode placement.  We used scans from within three years of the recording, so
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changes in body composition may have occurred.  Also, the images were in the 
fasting state; the stomach position and angle can change after a meal.  To account 
for this variability, we defined a 120-degree window for normal slow wave 
propagation direction.  Other localization approaches can be used in subsequent 
studies (e.g., ultrasound) that do not result in radiation exposure and provide 
measurements at the time of array placement.  Another limitation of our study was 
that the gastric emptying test was not performed at the time of the HR-EGG 
recording and symptom assessment.  Symptoms are dynamic and there is 
longitudinal variability in gastric emptying (48–50); a stronger correlation between 
gastric emptying and EGG has been previously reported when conducted 
simultaneously (51).  We did not conduct HR-EGG measurements during the gastric 
emptying study because our recording equipment did now allow patients to move 
between images.  Simultaneous measurements could be made in future studies 
using a recently developed wireless bioamplifier system (52).
In conclusion, HR-EGG has the potential to address several unmet needs in clinical 
gastroenterology.  As an objective measure that correlates with symptoms, HR-EGG 
can be used to quantify improvement and guide therapies.  The ability to subtype 
problems with gastric function beyond gastric emptying in both gastroparesis and 
functional dyspepsia can enable optimal targeted interventions, such as electrical 
pacing to normalize the gastric slow wave (53,54).  As a noninvasive measure, HR-
EGG can be easily repeated for multiple meals to account for inconsistencies in 
gastric emptying from day to day, which can be up to 31% (48–50).  Also, our 
methodological refinements pave the way for ambulatory monitoring that can be 
repeated ad infinitum (23), which leads to observations outside of the clinic under a 
variety of conditions, including sleep.  When combined with digital symptom 
annotation using smartphone technology, it can also create unique opportunities for
prospective symptom-association analyses, addressing challenges with symptom 
recall (55).  Continuing advances in establishing the pathophysiological basis for 
symptoms in gastroparesis and functional dyspepsia will enable increasing levels of 
precision in treating these common disorders.
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Study Highlights
The items under each heading should be bullet points that are very short, i.e., up to 
about 15 words.
1. WHAT IS CURRENT KNOWLEDGE
○ The link between foregut symptoms and gastric emptying is controversial.
○ Subtyping the specific pathophysiologic contributors to functional dyspepsia 
and gastroparesis can lead to targeted therapies.
○ Serosal electrical mapping has shown that spatial slow wave abnormalities 
are present in gastroparesis and functional gastrointestinal disorders.
2. WHAT IS NEW HERE
○ We detected spatial abnormalities of the slow wave noninvasively in 
gastroparesis and functional dyspepsia.
○ Abnormal slow wave direction correlated significantly with clinical symptom 
severity, regardless of gastric emptying status.
○ We propose that spatial parameters of the gastric slow wave be given 
important consideration in the evaluation of patients with functional 
dyspepsia and gastroparesis.
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Figures and Tables
Table 1. Characteristics for control, functional dyspepsia, and gastroparesis
subjects.
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Fig 1. A cutaneous HR-EGG electrode array (25 channels with 2cm electrode spacing) placed
over the antrum, which is identified from the subject’s abdominal CT scan.  The reference
and ground electrodes are on the subject’s right side.
Fig 2. Anatomical variation in the location of the pylorus determined from cross-sectional
imaging across 32 subjects.  The reference point is halfway between the xiphoid and
umbilicus.
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Fig 3. Coronal view of volumetric CT reconstructions for three representative subjects (top).
The dotted blue line indicates the coronal projection of the medial axis of the stomach.
Polar histograms of HR-EGG estimated slow wave direction throughout the recording
(bottom).  The green region indicates mean stomach angle ± 60 degrees and the red line is
the most frequent slow wave direction.
Table 2. Descriptive statistics of study variables comparing the control, functional dyspepsia,
and gastroparesis groups.
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Fig 4. Circular plot showing robust correlation between HR-EGG parameters (e.g., abnormal
slow wave direction, speed, and percentage of sustained waves) with
bloating/distension/fullness, abdominal discomfort/pain and overall GSCI score across all
subjects (n = 32). Consistent with other findings, gastric emptying showed few associations
with symptoms and traditional EGG parameters had none.  Measures from similar categories
are grouped and only statistically significant correlations between categories are shown
(after Benjamini-Hochberg correction).  *Correlations with gastric emptying scintigraphy do
not include the control group (n = 25).
Fig 5. Scatter plot of percentage slow waves with abnormal propagation direction estimated
with HR-EGG and overall Gastroparesis Cardinal Symptom Index (GCSI) symptom score for
all subjects.  Solid circle indicates gastroparesis (n = 18), hollow circles represent functional
dyspepsia with normal gastric emptying (n = 7), and stars represent healthy controls (n =
7). The blue line is a linear least-squares regression and the light blue shading is the
corresponding 95% confidence interval (n = 32, r = 0.57, p < .001).
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Cover Letter
July 24, 2018
Dear Editors, 
Please find our manuscript entitled, “Abnormal Spatial Patterns on Cutaneous High-
Resolution Electrogastrogram Correlates with Symptom Severity in Functional 
Dyspepsia and Gastroparesis” that we are submitting for consideration for 
publication in the American Journal of Gastroenterology. 
Background and Results:  Our team has pioneered the cutaneous high-resolution
electrogastrogram (HR-EGG), which addresses the shortcomings of single and multi-
channel EGG measurements of the past.  In previous publications, we showed that 
HR-EGG along with methodological refinements (e.g., artifact removal, array 
placement) yield significantly improved correlation with gastric manometry and can 
noninvasively measure slow wave propagation direction and speed.  In this 
manuscript, we present our application of these techniques, for the first time, in a 
population with functional dyspepsia and gastroparesis.  Our key finding was that 
unlike traditional EGG measures and gastric emptying, the degree of spatial slow 
wave abnormalities measured by HR-EGG exhibited statistically significant 
correlation with numerous clinical symptoms (e.g., overall GCSI score, bloating, 
early satiety, pain).  Moreover, despite improved methodological refinements, the 
traditional EGG features did not have any statistically correlation with any symptom.
Significance and Impact:  HR-EGG has the potential to address several unmet 
needs in clinical gastroenterology.  As an objective measure that correlates with 
symptoms, HR-EGG can be used to quantify improvement and guide therapies.  The
ability to subtype problems with gastric function beyond gastric emptying in both 
gastroparesis and functional dyspepsia can enable targeted interventions, such as 
electrical pacing to normalize the gastric slow wave.  As a noninvasive measure, 
HR-EGG can be easily repeated for multiple meals to account for inconsistencies in 
gastric emptying from day to day, which can be up to 31%.  Also, our 
methodological refinements pave the way for ambulatory monitoring that can be 
repeated ad infinitum, which leads to observations outside of the clinic under a 
variety of conditions including sleep.  When combined with digital symptom 
annotation using smartphone technology, it can also create unique opportunities for
prospective symptom-association analyses, addressing challenges with symptom 
recall.
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We believe these findings will renew interest in advancing noninvasive 
gastrointestinal measurements to establish clinical utility.  Continuing advances in 
establishing the pathophysiological basis for symptoms in gastroparesis and 
functional dyspepsia will enable increasing levels of precision in treating these 
common disorders.
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This manuscript has not been published previously and is not under consideration 
for publication elsewhere. We have no conflicts of interest to disclose. As 
corresponding author, I have obtained permission from all co-authors for submission
of this manuscript. 
Thank you for considering our manuscript for publication in American Journal of 
Gastroenterology.
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